69 completed, 17 unknown, 4 terminated, 3 active not recruiting. 35 Phase 4, 25 Not applicable, 15 Phase 3, 10 Phase 2, 6 Phase 1.
Follow Salbutamol: new trials by email Literature Review of Salbutamol trials Research Report on Salbutamol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation Local Anesthesia With Conscious Sedation, General Anesthesia, VARIPULSE Pulsed Field Ablation System - Paroxysmal Atrial Fibrillation | Not applicable | Recruiting | China National Center for Cardiovascular Diseases | 390 | 2026-06-01 | 2026-10-16 |
| Effects of Salbutamol in Athletes and Implications for Screening and Sports Salbutamol, Placebo - Asthma, Healthy | Not applicable | Recruiting | University of British Columbia | 64 | 2025-10-30 | 2026-03-13 |
| Deciphering a Novel and Unique Brown Adipose Tissue Depot in Women Thermoneutral condition, Cold condition, Aerobic exercise condition - Cardiometabolic Diseases | Not applicable | Unknown | Universidad de Almeria | 40 | 2024-11-01 | 2024-05-23 |
| Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. Tezepelumab, Budesonide/formoterol, Albuterol/budesonide (AIRSUPRA®) - Severe Asthma | Phase 3 | Active not recruiting | AstraZeneca | 310 | 2024-09-30 | 2026-10-13 |
| Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients Salbutamol, Placebo - Walking Capacity, Amyotrophic Lateral Sclerosis | Phase 2 | Unknown | Assistance Publique - Hôpitaux de Paris | 36 | 2024-09-01 | 2024-04-12 |
| Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing Tonsillectomy Salbutamol, Budesonide, Saline - Preoperative Inhalation of Budesonide and Salbutamol in Children Undergoing Tonsillectomy | Phase 4 | Unknown | Assiut University | 87 | 2024-08-01 | 2023-12-06 |
| Nebulized Salbutamol in Acute Renal Colic Salbutamol, 0.9% Normal Saline, Diclofenac Injection - Renal Colic | Not applicable | Unknown | Oman Medical Speciality Board | 214 | 2024-07-01 | 2024-03-19 |
| CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma Salbutamol, Fluticason either Beclometasone or Budesonide - Asthma | Phase 2 | Unknown | Università degli Studi di Ferrara | 80 | 2024-06-18 | 2024-07-03 |
| The Regulatory Function of Inhaled Asthma Medication Salbutamol on Thermogenesis Salbutamol - Effect of Asthma Medication Salbutamol on Obesity | Early Phase 1 | Unknown | Tongji University | 30 | 2024-03-01 | 2024-03-19 |
| Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) Salbutamol, Ipratropium Bromide, Salbutamol plus Ipratropium Bromide - Asthma, Airway Obstruction | Not applicable | Unknown | Hat Yai Medical Education Center | 60 | 2024-02-17 | 2024-02-20 |
| Video Assisted Study of Salbutamol Response in Viral Wheezing Salbutamol - Wheezing | Recruiting | University of Oulu | 50 | 2023-10-23 | 2025-02-13 | |
| The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome nebulized epinephrine, Salbutamol - Shortness of Breath, Asthma in Children | Phase 4 | Completed | Oman Medical Speciality Board | 30 | 2023-10-15 | 2025-06-06 |
| 5 Versus 10 Units of Insulin in Hyperkalemia Management Insulin regular, Dextrose 50, salbutamol - Hyperkalemia, Potassium Imbalance | Phase 4 | Completed | Oman Medical Speciality Board | 384 | 2023-10-01 | 2025-12-22 |
| INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions Salbutamol, Placebo - IgE-mediated Abdominal Pain | Phase 3 | Terminated | Philippe Bégin | 24 | 2023-07-01 | 2025-05-21 |
| Evaluating Bronchodilator Response in Patients With Bronchiectasis spirometry, Salbutamol, placebo - Bronchiectasis, Cystic Fibrosis | Not applicable | Unknown | Rambam Health Care Campus | 96 | 2023-05-20 | 2023-07-06 |
| Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation salbutamol, Insulin - Liver Transplantation | Not applicable | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 100 | 2022-10-28 | 2022-10-21 |
| Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus Magnesium Sulfate 500 mg/ml+ ventolin, Ventolin - Status Asthmaticus | Phase 1 | Completed | Ziauddin University | 126 | 2022-01-01 | 2023-04-05 |
| the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial) Salbutamol, 0,9% Chloride Sodium - TTN, Respiratory Failure | Phase 3 | Active not recruiting | Medical University of Warsaw | 608 | 2021-12-31 | 2025-11-18 |
| Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB) Salbutamol, Placebo medication, Ozone - Asthma and/or Exercise Induced Bronchoconstriction, Ozone Air Pollution | Phase 4 | Completed | University of British Columbia | 18 | 2021-11-01 | 2025-03-14 |
| Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial Salbutamol, Placebo - Wheezing | Phase 4 | Withdrawn | UMC Utrecht | 2021-09-01 | 2021-07-23 |
Showing 20 of 97. Sign in to see all of them.
Asthma (39) · Pulmonary Disease, Chronic Obstructive (16) · Dyspnea (4) · Respiratory Sounds (4) · Cystic Fibrosis (3) · Insulin Resistance (3) · Airway Obstruction (2) · Bronchopulmonary Dysplasia (2) · Food Hypersensitivity (2) · Hyperkalemia (2) · Lung Diseases (2) · Motor Activity (2) · Pulmonary Eosinophilia (2) · Respiratory Insufficiency (2) · Tachycardia (2)
GlaxoSmithKline (11) · AstraZeneca (6) · University of British Columbia (4) · University of Copenhagen (4) · Assistance Publique - Hôpitaux de Paris (3) · Chiesi Farmaceutici S.p.A. (3) · Oman Medical Speciality Board (3) · Boehringer Ingelheim (2) · Novartis Pharmaceuticals (2) · Rambam Health Care Campus (2) · University of Saskatchewan (2) · Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ahmed Noaman (1) · All India Institute of Medical Sciences (1)
United Kingdom (12) · France (11) · Canada (10) · Germany (10) · United States (10) · Poland (7) · China (6) · Denmark (6) · Italy (6) · Spain (6) · Bulgaria (5) · Netherlands (5) · Finland (4) · Israel (4) · Russia (4)
Jordan A Guenette, PhD (2) · Alaa Zeitoun, Prof (1) · Alberto Papi, MD (1) · Alberto Papi, Professor (1) · Amanda Kim, MD (1) · Andrea Ludwig-Sengpiel, Dr. (1) · Ann van den Bruel, Professor (1) · Anne-Marie Kirsten, Dr. (1) · Anneliese Linnhoff, Dr. med. (1) · Beydon Nicole, MD (1) · Camilo Roa, MD (1)
PMID 12842854, PMID 1414806, PMID 16166619, PMID 17507703, PMID 18096541, PMID 19772514, PMID 20509942, PMID 20619624, PMID 21859484, PMID 21960699, PMID 22394648, PMID 23176887, PMID 24135893, PMID 24321801, PMID 25022447, PMID 26329352, PMID 27836009, PMID 27940287, PMID 28545804, PMID 29409488, PMID 29486489, PMID 29972634, PMID 30166326, PMID 30233808, PMID 30589607, PMID 30777086, PMID 31202957, PMID 31695864, PMID 32847923, PMID 33334936, PMID 33336283, PMID 33369570, PMID 35942814, PMID 36398740, PMID 36714639, PMID 38071986, PMID 38827880, PMID 40736776, PMID 41318901, PMID 41565838, PMID 42127033, PMID 42609784, PMID 7676971
2015 (2), 2008 (1), 2014 (1), 2017 (1), 2019 (1), P01HL108808 (1), R01AI075603 (1)